IRMD vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

IRMD

37.4
AI Score
VS
PAHC Wins

PAHC

41.5
AI Score

Investment Advisor Scores

IRMD

37score
Recommendation
SELL

PAHC

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IRMD PAHC Winner
Revenue 42.44M 1.12B PAHC
Net Income 11.04M 78.01M PAHC
Gross Margin 75.3% 33.7% IRMD
Net Margin 26.0% 7.0% IRMD
Operating Income 13.63M 146.24M PAHC
ROE 10.8% 21.6% PAHC
ROA 9.6% 5.4% IRMD
Total Assets 114.97M 1.45B PAHC
Cash 59.08M 54.93M IRMD
Current Ratio 9.46 3.17 IRMD

Relative Price Performance (Last 90 Days)

IRMD 1M: -6.4% · 3M: -5.7% PAHC 1M: +6.7% · 3M: +8.5%

Current Technical Phase

IRMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $87.85

PAHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 62

RSI (14): 61.7 · Price: $36.32

Fundamentals Snapshot

Metric IRMD PAHC
Market Cap
Forward P/E 36.5 10.5
Trailing P/E 49.0 14.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.3%
Operating Margin 0.3% 0.1%
EPS 1.77 2.38
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, PAHC is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.